- Home
- ACOG vs PMVP Comparison
ACOG vs PMVP Comparison
Compare ACOG & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACOG
- PMVP
- Stock Information
- Founded
- ACOG 2000
- PMVP 2013
- Country
- ACOG Canada
- PMVP United States
- Employees
- ACOG N/A
- PMVP N/A
- Industry
- ACOG
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ACOG
- PMVP Health Care
- Exchange
- ACOG Nasdaq
- PMVP Nasdaq
- Market Cap
- ACOG 80.3M
- PMVP 55.1M
- IPO Year
- ACOG N/A
- PMVP 2020
- Fundamental
- Price
- ACOG $10.69
- PMVP $1.20
- Analyst Decision
- ACOG Strong Buy
- PMVP Strong Buy
- Analyst Count
- ACOG 1
- PMVP 1
- Target Price
- ACOG $20.00
- PMVP $5.00
- AVG Volume (30 Days)
- ACOG 71.5K
- PMVP 278.5K
- Earning Date
- ACOG 08-14-2025
- PMVP 08-07-2025
- Dividend Yield
- ACOG N/A
- PMVP N/A
- EPS Growth
- ACOG N/A
- PMVP N/A
- EPS
- ACOG N/A
- PMVP N/A
- Revenue
- ACOG $2,928,654.00
- PMVP N/A
- Revenue This Year
- ACOG N/A
- PMVP N/A
- Revenue Next Year
- ACOG N/A
- PMVP N/A
- P/E Ratio
- ACOG N/A
- PMVP N/A
- Revenue Growth
- ACOG N/A
- PMVP N/A
- 52 Week Low
- ACOG $3.75
- PMVP $0.81
- 52 Week High
- ACOG $11.40
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- ACOG N/A
- PMVP 57.96
- Support Level
- ACOG N/A
- PMVP $0.96
- Resistance Level
- ACOG N/A
- PMVP $1.14
- Average True Range (ATR)
- ACOG 0.00
- PMVP 0.07
- MACD
- ACOG 0.00
- PMVP -0.00
- Stochastic Oscillator
- ACOG 0.00
- PMVP 65.28
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.